MSM at Highest Risk for HIV Acquisition Express Greatest Interest and Preference for Injectable Antiretroviral PrEP Compared to Daily, Oral Medication
Crossref DOI link: https://doi.org/10.1007/s10461-017-1972-6
Published Online: 2017-11-08
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Biello, Katie B.
Mimiaga, Matthew J.
Santostefano, Christopher M.
Novak, David S.
Mayer, Kenneth H.
Funding for this research was provided by:
ViiV Healthcare
Harvard University Center for AIDS Research (P30 AI060354)
License valid from 2017-11-08